Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis

Thiazolidinediones are synthetic peroxisome proliferator-activated receptor γ agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the mechanism by which thiazolidinediones augment fract...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dongfeng, Shi, Zhenqi, Warriner, Amy H., Qiao, Ping, Hong, Huixian, Wang, Yongjun, Feng, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102552/
https://www.ncbi.nlm.nih.gov/pubmed/25032991
http://dx.doi.org/10.1371/journal.pone.0102706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102552/
https://www.ncbi.nlm.nih.gov/pubmed/25032991
http://dx.doi.org/10.1371/journal.pone.0102706

Ejemplares similares